QT
LENZ

Quantbot Technologies’s LENZ Therapeutics LENZ Stock Holding History

Quantbot Technologies’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,879
Closed -$270K – 2229
2025
Q4 		$270K Buy
+16,879
New +$492K 0.01% 1146
2023
Q2 		– Sell
-229
Closed -$3.92K – 2037
2023
Q1 		$3.92K Hold
229
– – ﹤0.01% 1451
2022
Q4 		$5.31K Hold
229
– – ﹤0.01% 1552
2022
Q3 		$5K Buy
+229
New +$5.46K ﹤0.01% 1479

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Quantbot Technologies's LENZ Position: Q1 2026 in Review

Quantbot Technologies sold out of LENZ Therapeutics (LENZ) in Q1 2026, closing a stake of 16,879 shares — an estimated $270K sold.

Quantbot Technologies first reported a position in LENZ in Q3 2022 and held it in 4 quarters. The position peaked at $270K in Q4 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Quantbot Technologies reported no remaining LENZ Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 16,879 LENZ Therapeutics shares in Q1 2026, an estimated $270K.
  • Quantbot Technologies first reported a position in LENZ Therapeutics in Q3 2022 and held it in 4 quarters.
  • Quantbot Technologies's LENZ Therapeutics position peaked at $270K in Q4 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.